+91
By proceeding, you agree to all T&C*
Didn't receive the code? Resend
ANG ANG

ANG Lifesciences India Share Price

₹31.42 +0 (0%)
36.77% Fall from 52W High

14 Aug, 2026 4:00 PM (IST)

ANG Lifesciences India live price: ₹31.42. It opened at ₹31 vs previous close ₹31; intraday high/low: ₹32/₹31. The 50 & 200 DMA stand at ₹32.80/₹30.40.

ANG Lifesciences India Performance

  • Today's Low
  • ₹31
  • Today's High
  • ₹32
  • 52 Week Low
  • ₹18
  • 52 Week High
  • ₹50
  • Open Price₹31
  • Previous Close₹31
  • Volume713
  • 50 DMA₹32.80
  • 100 DMA₹31.10
  • 200 DMA₹30.40

ANG Lifesciences India Chart

Investment Returns

  • Over 1 Month -5.3%
  • Over 3 Month + 15.51%
  • Over 6 Month + 20.85%
  • Over 1 Year + 8.8%

Smart Investing Starts Here Start SIP with ANG Lifesciences India for Steady Growth!

Invest Now

ANG Lifesciences India Fundamentals Fundamentals refer to the financial data that companies report on a quarterly or annual basis.

  • P/E Ratio
  • -3.1
  • PEG Ratio
  • 0.2
  • Market Cap Cr
  • 41
  • P/B Ratio
  • 0.8
  • Average True Range
  • 1.9
  • EPS
  • -10.2
  • Dividend Yield
  • 0
  • MACD Signal
  • -0.6
  • RSI
  • 41.08
  • MFI
  • 36.17

Latest Stock News Updates

ANG Lifesciences India Ltd - 540694 - Submission Of Standalone And Consolidated Unaudited Financial Results For The Quarter Ended On 30.06.2026 Under Regulation 33 Of The SEBI (LODR) Regulations, 2015

Financial Results 30.06.2026.

ANG Lifesciences India Ltd - 540694 - Board Meeting Outcome for Board Meeting Outcome For Submission Of Standalone And Consolidated Unaudited Financial Results For The Quarter Ended On 30.06.2026 Under Regulation 33 Of The SEBI (LODR) Regulations, 2015

Submission of standalone and consolidated unaudited financial results for the quarter ended on 30.06.2026 under Regulation 33 of the SEBI (LODR) Regulations, 2015

ANG Lifesciences India Ltd - 540694 - Board Meeting Intimation for Consideration And Approval Of Standalone & Consolidated Unaudited Financial Results For The Quarter Ended 30-06-2026.

ANG Lifesciences India Ltdhas informed BSE that the meeting of the Board of Directors of the Company is scheduled on 14/08/2026 ,inter alia, to consider and approve the Standalone and Consolidated Unaudited Financial Results for the quarter ended June 30, 2026.

ANG Lifesciences India Financials

ANG Lifesciences India Technicals

EMA & SMA

Current Price
₹31.42
0 (0%)
pointer
  • Bearish Moving Average 11
  • Bullish Moving Average 5
  • 20 Day
  • ₹33.20
  • 50 Day
  • ₹32.80
  • 100 Day
  • ₹31.10
  • 200 Day
  • ₹30.40

Resistance and Support

31.47 Pivot Speed
  • R3 31.60
  • R2 31.60
  • R1 31.50
  • S1 31.40
  • S2 31.30
  • S3 31.20

ANG Lifesciences India Corporate Actions - Bonus, Splits, Dividends

Date Purpose Remarks
2026-08-14 Quarterly Results
2026-05-30 Audited Results
2026-02-14 Quarterly Results
2025-11-14 Quarterly Results
2025-08-14 Quarterly Results
Date Purpose Remarks
2021-11-04 INTERIM Rs.1.00 per share(10%)Interim Dividend
View ANG Lifesciences India Dividend History Arrow
Date Purpose Remarks
2022-07-14 Bonus Bonus issue in the ratio of 1:4 of Rs. 10/-
2021-09-23 Bonus Bonus issue in the ratio of 1:1 of Rs. 10/-

ANG Lifesciences India Shareholding Pattern

70.6%
29.4%
0%

About ANG Lifesciences India

ANG Lifesciences India engaged in the business of manufacturing of Pharmaceuticals Products and Formulations. View More
  • NSE Symbol
  • ANG
  • BSE Symbol
  • 540694
  • ISIN
  • INE236W01016

Similar Stocks to ANG Lifesciences India

ANG Lifesciences India FAQs

ANG Lifesciences India share price is ₹31 As on 15 August, 2026 | 03:55

The Market Cap of ANG Lifesciences India is ₹41 Cr As on 15 August, 2026 | 03:55

The P/E ratio of ANG Lifesciences India is -3.1 As on 15 August, 2026 | 03:55

The PB ratio of ANG Lifesciences India is 0.8 As on 15 August, 2026 | 03:55

The 52 week High & Low of ANG Lifesciences India is ₹49.7/₹17.6 respectively As on 15 August, 2026 | 03:55

Open FREE Demat Account

Be a part of 5paisa community - The first listed discount broker of India.

+91

By proceeding, you agree to all T&C*

footer_form

Disclaimer: Investment in securities market are subject to market risks, read all the related documents carefully before investing. For detailed disclaimer please Click here.

Q2FY23